{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:49:31Z","timestamp":1794372571577,"version":"4.9.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,9,19]]},"abstract":"\n Importance<\/jats:title>\n Hypertensive disorders of pregnancy are a leading cause of pregnancy-related morbidity and mortality in the US.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To conduct a targeted systematic review to update the evidence on the effectiveness of screening for hypertensive disorders of pregnancy to inform the US Preventive Services Task Force.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n MEDLINE and the Cochrane Central Register of Controlled Trials for relevant studies published between January 1, 2014, and January 4, 2022; surveillance through February 21, 2023.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n English-language comparative effectiveness studies comparing screening strategies in pregnant or postpartum individuals.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n Two reviewers independently appraised articles and extracted relevant data from fair-or good-quality studies; no quantitative synthesis was conducted.<\/jats:p>\n <\/jats:sec>\n \n Main outcomes and measures<\/jats:title>\n Morbidity or mortality, measures of health-related quality of life.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The review included 6 fair-quality studies (5 trials and 1 nonrandomized study; N\u2009=\u200910\u202f165) comparing changes in prenatal screening practices with usual care, which was routine screening at in-person office visits. No studies addressed screening for new-onset hypertensive disorders of pregnancy in the postpartum period. One trial (n\u2009=\u20092521) evaluated home blood pressure measurement as a supplement to usual care; 3 trials (total n\u2009=\u20095203) evaluated reduced prenatal visit schedules. One study (n\u2009=\u20092441) evaluated proteinuria screening conducted only for specific clinical indications, compared with a historical control group that received routine proteinuria screening. One additional trial (n\u2009=\u200980) only addressed the comparative harms of home blood pressure measurement. The studies did not report statistically significant differences in maternal and infant complications with alternate strategies compared with usual care; however, estimates were imprecise for serious, rare health outcomes. Home blood pressure measurement added to prenatal care visits was not associated with earlier diagnosis of a hypertensive disorder of pregnancy (104.3 vs 106.2 days), and incidence was not different between groups in 3 trials of reduced prenatal visit schedules. No harms of the different screening strategies were identified.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This review did not identify evidence that any alternative screening strategies for hypertensive disorders of pregnancy were more effective than routine blood pressure measurement at in-person prenatal visits. Morbidity and mortality from hypertensive disorders of pregnancy can be prevented, yet American Indian\/Alaska Native persons and Black persons experience inequitable rates of adverse outcomes. Further research is needed to identify screening approaches that may lead to improved disease detection and health outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2023.4934","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T11:01:05Z","timestamp":1695034865000},"page":"1083","source":"Crossref","is-referenced-by-count":32,"title":["Screening for Hypertensive Disorders of Pregnancy"],"prefix":"10.1001","volume":"330","author":[{"given":"Jillian T.","family":"Henderson","sequence":"first","affiliation":[{"name":"Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Webber","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel G.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"},{"name":"CareOregon, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly K.","family":"Vesco","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"jus230006r1","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin Summary, number 222.","volume":"135","author":"American College of Obstetrician and Gynecologists","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"4","key":"jus230006r2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy.","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"jus230006r3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.preghy.2021.09.002","article-title":"Hypertension at delivery hospitalization\u2014United States, 2016-2017.","volume":"26","author":"DeSisto","year":"2021","journal-title":"Pregnancy Hypertens"},{"issue":"18","key":"jus230006r4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.15585\/mmwr.mm6818e1","article-title":"Vital signs: pregnancy-related deaths, United States, 2011\u20132015, and strategies for prevention, 13 states, 2013\u20132017.","volume":"68","author":"Petersen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"jus230006r7","doi-asserted-by":"publisher","first-page":"405.e1","DOI":"10.1016\/j.ajog.2018.07.002","article-title":"Contribution of hypertension to severe maternal morbidity.","volume":"219","author":"Hitti","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"jus230006r8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/AOG.0000000000002937","article-title":"Racial and ethnic disparities in the incidence of severe maternal morbidity in the United States, 2012-2015.","volume":"132","author":"Admon","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"4","key":"jus230006r9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s40615-019-00577-w","article-title":"Racial and ethnic disparities in severe maternal morbidity in the United States.","volume":"6","author":"Liese","year":"2019","journal-title":"J Racial Ethn Health Disparities"},{"issue":"5","key":"jus230006r10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1055\/a-1886-5404","article-title":"The association of race and ethnicity with severe maternal morbidity among individuals diagnosed with hypertensive disorders of pregnancy.","volume":"40","author":"Palatnik","year":"2023","journal-title":"Am J Perinatol"},{"issue":"35","key":"jus230006r11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.15585\/mmwr.mm6835a3","article-title":"Racial\/ethnic disparities in pregnancy-related deaths\u2014United States, 2007-2016.","volume":"68","author":"Petersen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"jus230006r12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/AOG.0000000000002441","article-title":"Racial disparities in adverse pregnancy outcomes and psychosocial stress.","volume":"131","author":"Grobman","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"21","key":"jus230006r13","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1080\/14767058.2019.1581522","article-title":"Preeclampsia outcomes at delivery and race.","volume":"33","author":"Gyamfi-Bannerman","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"10","key":"jus230006r15","first-page":"1531","article-title":"Predictors of eclampsia in California.","volume":"29","author":"Esakoff","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"jus230006r16","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.2105\/AJPH.2021.306375","article-title":"Racial and ethnic disparities in maternal mortality in the United States using enhanced vital records, 2016-2017.","volume":"111","author":"MacDorman","year":"2021","journal-title":"Am J Public Health"},{"issue":"2","key":"jus230006r17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/GRF.0000000000000349","article-title":"Reducing disparities in severe maternal morbidity and mortality.","volume":"61","author":"Howell","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"jus230006r18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ogc.2020.11.005","article-title":"Racial\/ethnic inequities in pregnancy-related morbidity and mortality.","volume":"48","author":"Minehart","year":"2021","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"2","key":"jus230006r19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1089\/jwh.2020.8890","article-title":"Maternal mortality among American Indian\/Alaska Native women: a scoping review.","volume":"30","author":"Heck","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"issue":"16","key":"jus230006r20","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for preeclampsia: US Preventive Services Task Force recommendation statement.","volume":"317","author":"US Preventive Services Task Force","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"jus230006r21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy.","volume":"122","author":"American College of Obstetricians and Gynecologists (ACOG)","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"jus230006r24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations, I: critical appraisal of existing approaches.","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"jus230006r26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/jama.1996.03530350029030","article-title":"Effect of frequency of prenatal care visits on perinatal outcome among low-risk women: a randomized controlled trial.","volume":"275","author":"McDuffie","year":"1996","journal-title":"JAMA"},{"issue":"2","key":"jus230006r27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/bjo.2000.107.issue-2","article-title":"Antenatal home blood pressure monitoring: a pilot randomised controlled trial.","volume":"107","author":"Ross-McGill","year":"2000","journal-title":"BJOG"},{"issue":"7030","key":"jus230006r28","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/bmj.312.7030.546","article-title":"A randomised controlled trial comparing two schedules of antenatal visits: the antenatal care project.","volume":"312","author":"Sikorski","year":"1996","journal-title":"BMJ"},{"issue":"17","key":"jus230006r29","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1001\/jama.2022.4712","article-title":"Effect of self-monitoring of blood pressure on diagnosis of hypertension during higher-risk pregnancy: the BUMP 1 randomized clinical trial.","volume":"327","author":"Tucker","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"jus230006r30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0091-2182(97)00027-X","article-title":"Evaluation of a reduced-frequency prenatal visit schedule for low-risk women at a free-standing birthing center.","volume":"42","author":"Walker","year":"1997","journal-title":"J Nurse Midwifery"},{"issue":"3","key":"jus230006r31","first-page":"214","article-title":"Indicated vs. routine prenatal urine chemical reagent strip testing.","volume":"52","author":"Rhode","year":"2007","journal-title":"J Reprod Med"},{"issue":"10294","key":"jus230006r33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(21)00668-1","article-title":"Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.","volume":"398","author":"Palmer","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"jus230006r34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.5854","article-title":"Comparison between in-person and audio-only virtual prenatal visits and perinatal outcomes.","volume":"4","author":"Duryea","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"jus230006r35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ajog.2009.10.864","article-title":"Racial\/ethnic disparities in obstetric outcomes and care: prevalence and determinants.","volume":"202","author":"Bryant","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"S1","key":"jus230006r37","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.2105\/AJPH.2018.304883","article-title":"The National Institute on Minority Health and Health Disparities research framework.","volume":"109","author":"Alvidrez","year":"2019","journal-title":"Am J Public Health"},{"issue":"4","key":"jus230006r38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1037\/hea0000242","article-title":"Understanding associations among race, socioeconomic status, and health: patterns and prospects.","volume":"35","author":"Williams","year":"2016","journal-title":"Health Psychol"},{"issue":"10077","key":"jus230006r39","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions.","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"},{"issue":"2S","key":"jus230006r41","doi-asserted-by":"publisher","first-page":"S1211","DOI":"10.1016\/j.ajog.2020.10.027","article-title":"Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy.","volume":"226","author":"Hauspurg","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"jus230006r42","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/JPN.0000000000000399","article-title":"Continued disparities in postpartum follow-up and screening among women with gestational diabetes and hypertensive disorders of pregnancy: a systematic review.","volume":"33","author":"Jones","year":"2019","journal-title":"J Perinat Neonatal Nurs"},{"issue":"5","key":"jus230006r43","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/AOG.0000000000002628","article-title":"ACOG committee opinion No. 736 summary: optimizing postpartum care.","volume":"131","author":"American College of Obstetrician and Gynecologists","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"4","key":"jus230006r44","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jnma.2018.10.016","article-title":"Strengthening the postpartum transition of care to address racial disparities in maternal health.","volume":"111","author":"Essien","year":"2019","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"jus230006r45","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/AOG.0000000000003508","article-title":"Clinical course, associated factors, and blood pressure profile of delayed-onset postpartum preeclampsia.","volume":"134","author":"Redman","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"4","key":"jus230006r46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ajog.2020.12.016","article-title":"The evolution of prenatal care delivery guidelines in the United States.","volume":"224","author":"Peahl","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"jus230006r23","author":"Henderson","year":"2023"},{"key":"jus230006r25","volume-title":"Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update","author":"Berkman","year":"2014"},{"key":"jus230006r32","doi-asserted-by":"crossref","DOI":"10.23970\/AHRQEPCCER257","volume-title":"Schedule of Visits and Televisits for Routine Antenatal Care: A Systematic Review: Comparative Effectiveness Review No. 257","author":"Balk","year":"2022"},{"key":"jus230006r5","unstructured":"Pregnancy Mortality Surveillance System. Centers for Disease Control and Prevention. Accessed January 17, 2023. https:\/\/www.cdc.gov\/reproductivehealth\/maternal-mortality\/pregnancy-mortality-surveillance-system.htm"},{"key":"jus230006r6","unstructured":"Chew? LC, Verma? RP. Fetal Growth Restriction. National Center for Biotechnology Information. Published 2020. Accessed April 19, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562268\/"},{"key":"jus230006r14","unstructured":"Fingar? KR, Mabry-Hernandez? I, Ngo-Metzger? Q, Wolff? T, Steiner? CA, Elixhauser? A. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs: statistical brief #222: delivery hospitalizations involving preeclampsia and eclampsia, 2005-2014. National Center for Biotechnology Information. Published 2017. Accessed January 17, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK442039\/"},{"key":"jus230006r22","unstructured":"US Preventive Services Task Force Procedure Manual. US Preventive Services Task Force. Updated May 2021. Accessed April 27, 2023. https:\/\/uspreventiveservicestaskforce.org\/uspstf\/about-uspstf\/methods-and-processes\/procedure-manual"},{"key":"jus230006r36","unstructured":"Pregnancy-related deaths: data from 14 US maternal mortality review committees, 2008-2017. Centers for Disease Control and Prevention. Published 2021. Accessed April 27, 2023. https:\/\/www.cdc.gov\/reproductivehealth\/maternal-mortality\/erase-mm\/mmr-data-brief.html"},{"key":"jus230006r40","unstructured":"NIMHD research framework. National Institute on Minority Health and Health Disparities. Accessed November 19, 2021. http:\/\/www.nimhd.nih.gov\/about\/overview\/research-framework\/"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2809681\/jama_henderson_2023_us_230006_1695054955.19258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T12:37:24Z","timestamp":1695127044000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2809681"}},"subtitle":["Updated Evidence Report and Systematic Review for the US Preventive Services Task Force"],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,9,19]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.4934","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,19]]}}}